Cancer Medicines Forum workshop
5 April 2024
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate treatment optimisation in Europe with a focus on post-licensing questions based on clinically relevant end-points for patients in the healthcare setting.
The CMF will report its observations and preliminary solutions to address treatment optimisation at a hybrid workshop at the EMA under the Auspices of the EU Belgian Presidency.
Date: Friday, 5 April 2024, 1:00-6:00 PM (CEST)
Location: European Medicines Agency, Amsterdam
Registration will close on 1 March 2024 for in-person participation and will remain open until 29 March 2024 for online participation.
Next events
CDDF & EORTC Joint Workshop on Health Technology Assessment in Cancer Drug Development
5 October - 6 October
Brussels, Belgium (hybrid)
EORTC Cutaneous Lymphoma Tumour Group Annual Meeting 2026
8 October - 10 October
Berlin, Germany
EORTC Soft Tissue and Bone Sarcoma Group Autumn Meeting 2026
8 October - 9 October
Birmingham, UK
EORTC Lung Cancer Group Autumn Meeting 2026
9 October
EORTC HQ, Brussels, Belgium
ESOI Touchdown 2026
29 October @ 08:00 - 31 October @ 14:00
Heidelberg, DE
